We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease
News

Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease

Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease
News

Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Lab901 and Biofortuna announced that they will collaborate on the launch of an automated PCR Dx system for detection of certain HLA-related diseases such as coeliac disease.

Lab901 will be optimizing its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics kits for the detection of Coeliac disease, and other HLA related disease such as reactive arthritis, diabetes and drug hypersensitivity.

Lab901’s automated ScreenTape PCR diagnostics platform includes an instrument, pre-packed consumables and analysis software that automatically interprets results, simplifying and speeding up gel electrophoresis.

“We are delighted that Biofortuna have chosen to optimize kits for use on the increasingly popular ScreenTape platform”, commented Richard Rowling, Lab901’s Sales & Marketing Director. “ScreenTape has won acceptance globally for the automated detection, analysis and interpretation of highly multiplexed PCR diagnostic tests and we feel the addition of new content from Biofortuna will help both companies grow sales rapidly”, he added.

Financial terms were not disclosed.
Advertisement